Andrews, Joseph Matthew James (2006) Cytokine and hormone modulation of HLA-DR molecules in breast carcinoma cell lines. Masters thesis, Memorial University of Newfoundland.
- Accepted Version
Available under License - The author retains copyright ownership and moral rights in this thesis. Neither the thesis nor substantial extracts from it may be printed or otherwise reproduced without the author's permission.
Cytokines and steroidal hormones modulate HLA-DR expression on breast cancer cell lines (BCCL). This study compared the individual and combined quantitative effects of IFN-γ, IL-4, TGF-β1, and 17β-estradiol on HLA-DR expression on 8 human breast carcinoma cell lines (MCF-7, T47D, BT-474, BT-20, MDA MB 157, MDA MB 231, MDA MB 468, SKBR3) through the use of monoclonal antibodies and flow cytometry and CELISA. -- Due to problems with the reconstitution solvents, we were unable to determine the effects of estradiol treatment on HLA-DR expression. However, comparison of constitutive and IFN-γ-induced HLA-DR expression in medium containing or depleted of estrogen illustrated that media components, particularly estrogen, significantly modulated HLA-DR expression on BCCL. -- We report distinct patterns in cytokine modulation of HLA-DR expression when co-cultured in estrogen-depleted media. Although IFN-γ increased HLA-DR expression on all cell lines, addition of IL-4 selectively increased HLA-DR expression on MCF-7 and SKBR3, and addition of TGF-β1 selectively increased expression on BT-20 and SKBR3. Furthermore, analysis of TGF-β1 sensitivity through detection of phosphorylated Smad2 and Smad3 proteins (P-Smad2, P-Smad3) by Western blotting showed differential expression of P-Smad proteins in BCCL, as both BT-20 and SKBR3 expressed P-Smad3 but not P-Smad2. Since P-Smad3 is thought to inhibit CIITA in most cell types, we suggest that TGF-β1 mediated up-regulation of HLA-DR on breast cancer cell lines may be mediated through a Smad-independent pathway.
|Item Type:||Thesis (Masters)|
|Additional Information:||Includes bibliographical references (leaves 159-192).|
|Department(s):||Medicine, Faculty of|
|Library of Congress Subject Heading:||Breast--Cancer--Immunological aspects; HLA class II antigens.|
|Medical Subject Heading:||Breast Neoplasms--immunology; HLA-DR Antigens.|
Actions (login required)